Ong Yee Lung - 01 Sep 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
10%+ Owner
Signature
/s/ Ong Yee Lung
Issuer symbol
CYCC
Transactions as of
01 Sep 2025
Net transactions value
$0
Form type
3
Filing time
02 Sep 2025, 06:06:17 UTC
Next filing
04 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ong Yee Lung 10%+ Owner 9 JALAN LAWA 3 TAMAN PELANGI, INDAH ULU TIRAM, JOHOR BAHRU, MALAYSIA /s/ Ong Yee Lung 01 Sep 2025 0002081473

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYCC Common Stock 218,000 01 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYCC Series A Common Stock Warrants 01 Sep 2025 Common Stock 218,000 $7.65 Direct F1
holding CYCC Series B Common Stock Warrants 01 Sep 2025 Common Stock 218,000 $9.00 Direct F1
holding CYCC Series C Common Stock Warrants 01 Sep 2025 Common Stock 218,000 $10.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with a securities purchase agreement dated June 20, 2025, Mr. Ong acquired 218,000 shares of the Company's common stock. He also received series A, series B and series C common stock purchase warrants to each purchase 218,000 shares of the Company's common stock, respectively. The beneficial ownership limitation of 4.99% under each such warrant was removed on September 1, 2025